EarningsNAVANAPHAR
NAVANAPHAR Earnings Update
Announcement summary
- What happened
- NAVANAPHAR published a corporate disclosure on 4 June 2026. Read the full announcement for details.
- Company
- Navana Pharmaceuticals PLC
- Announcement published
Original announcement
(Q3 Un-audited): EPS was Tk. 1.22 for Jan-March 2026 as against Tk. 1.01 for Jan-March 2025; EPS was Tk. 4.59 for July 2025-March 2026 as against Tk. 3.49 for July 2024-March 2025. Diluted EPS was Tk. 1.20 for Jan-March 2026 and Diluted EPS was Tk. 4.55 for July 2025-March 2026. NOCFPS was Tk. 15.44 for July 2025-March 2026 as against Tk. 10.22 for July 2024-March 2025. NAV per share was Tk. 49.53 as on March 31, 2026 and Tk. 45.29 as on June 30, 2025. (cont.1)
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 6a20f5e889e237668988c07a
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from NAVANAPHAR
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.